| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 539277 | Alstone Textiles Alstone Textiles (India) Ltd | 07-Oct-2026 | Alstone Textiles (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Wednesday 07th October 2026 at the corporate office of the Company at 47/18 Old Rajinder Nagar Near Rajendra Place Metro Station New Delhi-110060 with respect to following: 1. To consider and approve the Unaudited (Standalone) Financial Results of the Company for the Quarter and half year ended on 30th September 2026. |
| 522004 | Batliboi Batliboi Ltd | 07-Oct-2026 | Batliboi Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve 1. the variation of the terms of 692480 1% Redeemable Non-Cumulative Preference Shares of Rs. 100/- each held by Mr. Nirmal Bhogilal Promoter and Chairman of the Company so as to render the same convertible into equity shares of the Company in accordance with Section 48 of the Companies Act 2013 and the subsequent conversion thereof into equity shares; 2. the conversion of the unsecured loan of Rs. 150000000/- extended by Mr. Nirmal Bhogilal Promoter and Chairman of the Company into equity shares of the Company in accordance with Section 62(3) of the Companies Act 2013; and 3. the issue and allotment of equity shares of the Company on a preferential basis for consideration other than cash pursuant to (i) and (ii) above subject to such regulatory/statutory approvals including the approval of the shareholders of the Company as may be required. We request you to take the above information on record |
| 543848 | Dev Labtech Dev Labtech Venture Ltd | 07-Oct-2026 | Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve 1. To increase authorized share capital of the Company. 2. To consider and evaluate proposals for raising of funds by way of issue of equity shares or any other eligible convertible securities through preferential allotment subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company. |
| 540701 | Dishman Carbogen Dishman Carbogen Amcis Ltd | 07-Oct-2026 | Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve a) the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required; b) the proposal of modification/change in security in respect of the Company''s Tranche II of 1,500 Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non- Convertible Debentures of face value of ?1,00,000/- each, aggregating to ?15 Crore, allotted on September 28, 2026 having Scrip Code 978230. |
| 541741 | FratelliVineyard Fratelli Vineyards Ltd | 07-Oct-2026 | Fratelli Vineyards Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve This is in continuation to the meeting of the Board of Directors of Fratelli Vineyards Limited (the Company) held on Thursday October 01 2026 approving the Rights Issue of Partly paid-up Equity shares for an amount not exceeding Rs. 30 Crores having face value of Rs.10/- each to the eligible Equity Shareholders of the Company we would like to inform you that a meeting of the Rights Issue Committee of the Board of Directors of the Company is scheduled to be held on October 07 2026 inter alia to consider the Issue Price Entitlement Ratio and other modalities related to the Rights Issue subject to the receipt of in-principle approval from the stock exchanges and/or such other regulatory approvals as may be required |
| 531911 | Galaxy Agrico Galaxy Agrico Exports Ltd | 07-Oct-2026 | Galaxy Agrico Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. To consider and approve the fixation of Record Date for the purpose of sub-division / split of the existing Equity Shares of the Company having face value of ?10/- (Rupees Ten only) each into Equity Shares having face value of ?1/- (Rupee One only). 2. Any other business with the permission of Chairperson. |
| 513309 | Golkonda Alumin. Golkonda Aluminium Extrusions Ltd | 07-Oct-2026 | Quarterly Results Golkonda Aluminium Extrusions Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Wednesday 07th October, 2026 at the Registered Office of the Company at 1003, 10th Floor, Vikram Tower, Rajendra place New Delhi - 110008 with respect to following: 1. To consider and approve the Unaudited (Standalone) Financial Results of the Company for the Quarter and half year ended on 30th September, 2026. This is also to inform that the Trading Window of the Company has been closed from 01st October, 2026 and will remain closed till the completion of 48 hours after the declaration of unaudited Financial Results of the Company for the quarter and half year ended on 30th September, 2026. 2. Any other agenda, with prior permission of Chairperson. |
| 526445 | Indrayani Biotec Indrayani Biotech Ltd | 07-Oct-2026 | Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve 1. Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026 along with the Limited Review Report by Statutory Auditors. 2. Proposal for the reconstitution of various Committees of the Board of Directors. |
| 539767 | Mega Nirman Mega Nirman & Industries Ltd | 07-Oct-2026 | Mega Nirman And Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 inter alia to consider and approve as per the pdf attached |
| 539519 | TAVEXIA LIFECARE TAVEXIA LIFECARE LIMITED | 07-Oct-2026 | Inter alia, to consider and discuss the following matter: 1. To further discuss and deliberate upon the matter relating to the proposed acquisition of up to 60% of the equity share capital of Meyonex Pharmaceuticals Limited, an unlisted public company having CIN: U74120MH2015PLC261024. The aforesaid matter is being considered with reference to the previous meeting of the Board of Directors of the Company held on Monday, 07th September, 2026, wherein the Board had considered and approved the proposal for acquisition of up to 60% of the equity share capital of Meyonex Pharmaceuticals Limited and authorised the designated representatives of the Company to undertake preliminary evaluation, due diligence, valuation and negotiations in relation thereto. The Board shall further discuss and deliberate upon the developments in the matter and decide the further course of action in relation to the proposed acquisition. 2. To consider and transact any other business with the permission of the Chairperson. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
